The transaction was valued at $6.89 billion (£5.14bn)
Elanco Animal Health has closed the acquisition of Bayer Animal Health in a deal worth $6.89 billion (£5.14bn).
Elanco said the deal would bring together their farm animal portfolios and allow them to ‘serve an even broader spectrum’ of the industry.
Jeff Simmons, president and chief executive of Elanco said they were creating a ‘purpose-driven independent global company dedicated to animal health’.
He said pets and protein had never been more important with food supply disruptions and increasing unemployment driving food security challenges around the world.
Mr Simmons added: “If COVID-19 has made anything clear – it is that the world has never needed animals and the work farmers and veterinarians do more.
“Together, we are better positioned to advocate for our customers, to deliver solutions to their greatest unmet needs, so they can keep healthy, sustainably sourced meat, milk, fish and eggs in the centre of the dinner table and healthy, active pets in the centre of families.
“Together, we have the potential to improve animal health and the lives of billions.”